Japanese Medical Equipment Stock News

Last week saw the newest full-year earnings release from Internet Initiative Japan Inc. ( TSE:3774 ), an important...

Terumo (TSE:4543) has wrapped up FY 2026 with Q4 revenue of ¥300.3b and basic EPS of ¥17.87, while trailing twelve month figures show revenue of ¥1.1t and EPS of ¥92.14 as earnings growth reached 16.2% and net margin stood at 12%, up from 11.3% a year earlier. Over the past two reported years in this dataset, quarterly revenue has moved from ¥263.9b in Q4 FY 2025 to ¥300.3b in Q4 FY 2026, with quarterly basic EPS shifting from ¥12.45 to ¥17.87 over the same period. This gives investors a...

Subaru (TSE:7270) FY 2026 earnings snapshot Subaru (TSE:7270) has wrapped up FY 2026 with Q4 revenue of ¥1.27t and basic EPS of ¥10.89, alongside net income of ¥7.8b. The trailing twelve months show revenue of ¥4.8t and EPS of ¥125.50. Across the past few reported quarters, revenue has ranged from ¥1.13t to ¥1.27t while quarterly EPS has swung between a loss of ¥10.19 and a profit of ¥75.03, giving investors a wide lens on how margins are being earned and where they are coming under...

Eisai (TSE:4523) has wrapped up FY 2026 with a mixed final quarter, reporting Q4 revenue of ¥205.4b alongside basic EPS of ¥11.53 loss, compared with trailing 12 month revenue of ¥825.4b and basic EPS of ¥136.78. Over recent reporting periods, revenue has ranged from ¥188.2b in Q4 FY 2025 to ¥219.9b in Q3 FY 2026, while quarterly EPS has moved between ¥3.36 and ¥84.31, giving investors a wide set of outcomes to assess. With margins sitting between modest trailing profitability and a loss in...

Yokohama Rubber Company (TSE:5101) has opened Q1 2026 with revenue of ¥303,806 million and basic EPS of ¥93.62, against a backdrop where trailing twelve month revenue stands at ¥1.26 trillion and EPS at ¥709.46, supported by a 75.3% rise in earnings over the last year. Over recent periods, revenue has moved from ¥1.09 trillion on a trailing basis at Q4 2024 to ¥1.23 trillion at Q4 2025 and ¥1.26 trillion at Q1 2026. Trailing EPS has shifted from ¥467.81 to ¥668.55 and then ¥709.46, shaping...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Shareholders might have noticed that Kajima Corporation ( TSE:1812 ) filed its full-year result this time last week...

Japan Post Bank (TSE:7182) has wrapped up FY 2026 with fourth quarter revenue of ¥482.2 billion and basic EPS of ¥41.5, alongside quarterly net income of ¥147.9 billion that feeds into trailing twelve month EPS of ¥147.1 and net income of ¥525.6 billion. Over recent quarters, the company has seen revenue move from ¥309.2 billion in Q4 FY 2025 to ¥455.5 billion in Q3 FY 2026 and then to ¥482.2 billion in Q4 FY 2026, while basic EPS has shifted from ¥29.3 to ¥38.4 and then ¥41.5 over the same...

Japan Post Insurance (TSE:7181) has wrapped up FY 2026 with fourth quarter revenue of ¥475.7 billion and basic EPS of ¥46.21. Trailing twelve month revenue sits at ¥2.9 trillion with EPS of ¥152.55, while earnings growth over the last year is reported at 36.7%. Over recent periods the company has seen revenue move from ¥3.8 trillion and EPS of ¥107.52 on a trailing basis in FY 2025 to the latest ¥2.9 trillion and ¥152.55. This has occurred alongside a trailing net margin of 5.8% compared with...

Japan Post Holdings (TSE:6178) has laid out its FY 2026 picture with fourth quarter revenue of about ¥3.0 trillion and basic EPS of ¥41.33, while trailing twelve month revenue sits at roughly ¥11.4 trillion and EPS at ¥129.14. Over recent periods, the company has seen quarterly revenue range from about ¥2.77 trillion to ¥3.11 trillion and EPS move between ¥22.78 and ¥41.33. This gives investors a clearer sense of the company’s run-rate ahead of forecasts that call for earnings growth...

Latest FY 2026 results: setting the scene Marui Group (TSE:8252) has wrapped up FY 2026 with fourth quarter revenue of ¥71.1b and basic EPS of ¥39.01, alongside trailing twelve month revenue of ¥276.9b and EPS of ¥158.35. The company has seen quarterly revenue move from ¥66.6b in FY 2025 Q4 to ¥71.1b in FY 2026 Q4, while quarterly EPS shifted from ¥41.75 to ¥39.01 over the same period. This gives investors a clear read on recent trading conditions and earnings power. With a trailing net...

It's been a good week for JGC Holdings Corporation ( TSE:1963 ) shareholders, because the company has just released its...

It's been a good week for Kirin Holdings Company, Limited ( TSE:2503 ) shareholders, because the company has just...

It's been a pretty great week for Honda Motor Co., Ltd. ( TSE:7267 ) shareholders, with its shares surging 13% to...

While Topre Corporation ( TSE:5975 ) might not have the largest market cap around , it saw a decent share price growth...

As inflationary pressures and rising energy costs continue to shape global markets, investors are increasingly seeking stability in dividend stocks, particularly within the dynamic Asian markets. In such an environment, a good dividend stock is often characterized by its ability to provide consistent income streams while maintaining resilience against broader economic challenges.

As of May 2026, Asian markets are navigating a complex landscape influenced by global economic factors such as rising energy costs and inflationary pressures, similar to trends observed in other major economies. Despite these challenges, the region's tech sector continues to garner attention due to its potential for high growth, driven by robust domestic demand and technological advancements. In this environment, a promising tech stock typically demonstrates strong innovation capabilities and...

As global markets grapple with rising inflation and energy costs, Asian equities present intriguing opportunities for value investors. In this context, identifying stocks trading below their intrinsic value can be particularly appealing, offering potential upside in a market environment characterized by cautious sentiment and economic uncertainties.

As global markets grapple with rising inflation and geopolitical uncertainties, the Asian market continues to present unique opportunities for investors, particularly in the small-cap sector. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to navigating these challenges; Nanjing Develop Advanced Manufacturing is one such company leading a trio of undiscovered gems in Asia.

Goodwill impairment hits guidance while dividend and FY2027 outlook steady Towa Pharmaceutical (TSE:4553) drew investor attention after announcing a large goodwill impairment at subsidiary Sunsho Pharmaceutical, which led to sharply reduced FY2026 profit guidance and raised questions about near term earnings quality. At the same time, the company kept its dividend plan unchanged and outlined expectations for higher sales and profit in FY2027. This combination puts the focus on how quickly...

Nomura Micro Science has reported its fiscal 2026 results, revealing steep declines in sales and profits but also an increased annual dividend to ¥81 per share under its TTT-26 growth plan. By pairing higher shareholder payouts with a forecast for a sharp earnings recovery in fiscal 2027, management is signaling confidence in a demand rebound despite recent operational weakness. Next, we’ll examine how the dividend increase and confident fiscal 2027 guidance shape Nomura Micro Science’s...

SoftBank Corp. has reported past full-year results for the 12 months to March 31, 2026, with sales of ¥7.04 trillion and net income of ¥550.76 billion, both higher than the prior year. The improvement in both basic and diluted earnings per share from continuing operations highlights how incremental profitability gains can compound meaningfully at SoftBank’s scale. Now we’ll examine how this uptick in full-year sales and net income may influence SoftBank’s existing investment narrative and...

Earlier this month, Capricor Therapeutics filed a lawsuit in New Jersey seeking to unwind its U.S. distribution deal with Nippon Shinyaku’s subsidiary over alleged pricing flaws and launch-preparation failures for Duchenne muscular dystrophy therapy Deramiocel, while Nippon Shinyaku also reported revenue growth, softer profit and an unchanged dividend for the year to March 2026. Ahead of its forecast for higher earnings in fiscal 2027, Nippon Shinyaku and Chugai applied in Japan to expand...

Earlier this week, Ship Healthcare Holdings reported its fiscal year 2026 results and held a board meeting to consider the distribution of surplus, outlining how it plans to return capital to shareholders. Alongside these disclosures, management highlighted key operational initiatives and a clearer shareholder return policy for fiscal year 2027, giving investors more detail on how future cash flows might be allocated between growth and returns. Next, we will examine how Ship Healthcare...